Hemodynamic benefit of rest and exercise optimization of cardiac resynchronization therapy

Echocardiography

Volumn 31, Issue 8, 2014, Pages 980-988

  Stanton, Tony ^a   Haluska, Brian A ^a   Leano, Rodel ^a   Marwick, Thomas H ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Brain natriuretic peptide; Cardiac resynchronization therapy; Echocardiography; Heart failure; Ventricular remodeling

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OXYGEN CONSUMPTION; RANDOMIZED CONTROLLED TRIAL; REST; BED REST; COMPLICATION; ECHOGRAPHY; ETIOLOGY; HEART LEFT VENTRICLE FUNCTION; KINESIOTHERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

AGED; BED REST; CARDIAC RESYNCHRONIZATION THERAPY; COMBINED MODALITY THERAPY; EXERCISE THERAPY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84908069465     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/echo.12506     Document Type: Article

References (30)

1. Gorcsan J, III, Abraham T, Agler DA, et al: Echocardiography for cardiac resynchronization therapy: Recommendations for performance and reporting - a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr 2008;21:191-213.
2. Sogaard P, Egeblad H, Pedersen AK, et al: Sequential versus simultaneous biventricular resynchronization for severe heart failure: Evaluation by tissue Doppler imaging. Circulation 2002;106:2078-2084.
3. Cazeau S, Leclercq C, Lavergne T, et al: Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-880.
4. Pak PH, Kass DA: Assessment of ventricular function in dilated cardiomyopathies. Curr Opin Cardiol 1995;10:339-344.
5. Burri H, Sunthorn H, Somsen A, et al: Optimizing sequential biventricular pacing using radionuclide ventriculography. Heart Rhythm 2005;2:960-965.
6. Lewis JF, Kuo LC, Nelson JG, et al: Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: Clinical validation of two new methods using the apical window. Circulation 1984;70:425-431.
7. Yu CM, Gorcsan J, III, Bleeker GB, et al: Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. Am J Cardiol 2007;100:1263-1270.
8. Thomas DE, Yousef ZR, Fraser AG: A critical comparison of echocardiographic measurements used for optimizing cardiac resynchronization therapy: Stroke distance is best. Eur J Heart Fail 2009;11:779-788.
9. Cleland JG, Daubert JC, Erdmann E, et al: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
10. Koglin J, Pehlivanli S, Schwaiblamir M, et al: Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001;38:1934-1941.
11. Mullens W, Grimm RA, Verga T, et al: Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol 2009;53:765-773.
12. Waggoner AD, de las Fuentes L, Davila RVG: Doppler echocardiographic methods for optimization of the atrioventricular delay during cardiac resynchronization therapy. Echocardiography. 2008;25:1047-1055.
13. Bertini M, Valzania C, Biffi M, et al: Interventricular delay optimization: A comparison among three different echocardiographic methods. Echocardiography 2010;27:38-43.
14. Rao RK, Kumar UN, Schafer J, et al: Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy: A randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing. Circulation 2007;115:2136-2144.
15. Valzania C, Eriksson MJ, Boriani G, et al: Cardiac resynchronization therapy during rest and exercise: Comparison of two optimization methods. Europace 2008;10:1161-1169.
16. Tamborero D, Vidal B, Tolosana JM, et al: Electrocardiographic versus echocardiographic optimization of the interventricular pacing delay in patients undergoing cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2011;22:1129-1134.
17. Vidal B, Sitges M, Marigliano A, et al: Optimizing the programation of cardiac resynchronization therapy devices in patients with heart failure and left bundle branch block. Am J Cardiol 2007;100:1002-1006.
18. Reinsch N, Konorza T, Woydowski D, et al: Iterative cardiac output measurement for optimizing cardiac resynchronization therapy: A randomized, blinded, crossover study. Pacing Clin Electrophysiol 2010;33:1188-1194.
19. Stanton T, Hawkins NM, Hogg KJ, et al: How should we optimize cardiac resynchronization therapy? Eur Heart J 2008;29:2458-2472.
20. Kyriacou A, Pabari PA, Francis DP: Cardiac resynchronization therapy is certainly cardiac therapy, but how much resynchronization and how much atrioventricular delay optimization? Heart Fail Rev 2012;17:727-736.
21. Berger R, Shankar A, Fruhwald F, et al: Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: An analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study. Eur Heart J 2009;30:2109-2116.
22. Bettencourt P, Azevedo A, Pimenta J, et al: N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168-2174.
23. Cohen-Solal A, Logeart D, Huang B, et al: Lowered B-type natri-uretic peptide in response to levosimendan or dobutamine treatmentis associated with improved survival in patients with severe acutely decompensated heart failure. J Am Coll Cardiol 2009;53:2343-2348.
24. Kedia N, Ng K, Apperson-Hansen C, et al: Usefulness of atrioventricular delay optimization using Doppler assessment of mitral inflow in patients undergoing cardiac resynchronization therapy. Am J Cardiol 2006;98:780-785.
25. Ellenbogen KA, Gold MR, Meyer TE, et al: Primary results from the SmartDelay determined AV optimization: A comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: A randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation 2010;122:2660-2668.
26. Khan FZ, Virdee MS, Read PA, et al: Impact of VV optimization in relation to left ventricular lead position: An acute haemodynamic study. Europace 2011;13:845-852.
27. Marsan NA, Bleeker GB, Van Bommel RJ, et al: Cardiac resynchronization therapy in patients with ischemic versus non-ischemic heart failure: Differential effect of optimizing interventricular pacing interval. Am Heart J 2009;158:769-776.
28. Coats AJ, Adamopoulos S, Radaelli A, et al: Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 1992;85:2119-2131.
29. Qamruddin S, Rafie R, Naqvi TZ: Discordant left and right ventricular optimal atrioventricular and interventricular delays during biventricular pacemaker optimization. Echocardiography 2013;30:751-758.
30. Otterstad JE, Froeland G, St John SM, et al: Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J 1997;18:507-513.